These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32914247)

  • 1. Early-stage mantle cell lymphoma-a rare entity with special characteristics and needs for treatment.
    Specht L;
    Ann Hematol; 2020 Dec; 99(12):2963-2964. PubMed ID: 32914247
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report.
    Jo JC; Kim SJ; Lee HS; Eom HS; Lee SI; Park Y; Lee JO; Lee Y; Yhim HY; Yang DH; Byun JM; Kang HJ; Kim HJ; Shin HJ; Yoo KH; Suh C;
    Ann Hematol; 2020 Feb; 99(2):223-228. PubMed ID: 31853704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and survival trends in mantle cell lymphoma.
    Epperla N; Hamadani M; Fenske TS; Costa LJ
    Br J Haematol; 2018 Jun; 181(5):703-706. PubMed ID: 28444739
    [No Abstract]   [Full Text] [Related]  

  • 4. Mantle Cell Lymphoma: Is It Time for a New Treatment Paradigm?
    Goy A
    Hematol Oncol Clin North Am; 2016 Dec; 30(6):1345-1370. PubMed ID: 27888885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mantle Cell Lymphoma-Time to Dismantle the Treatment Paradox.
    Yavorkovsky LL
    JAMA Oncol; 2018 May; 4(5):626-627. PubMed ID: 29494738
    [No Abstract]   [Full Text] [Related]  

  • 6. Personalized medicine in lymphoma: is it worthwhile? The mantle cell lymphoma experience.
    Dreyling M; Ferrero S;
    Haematologica; 2015 Jun; 100(6):706-8. PubMed ID: 26034112
    [No Abstract]   [Full Text] [Related]  

  • 7. Indolent mantle cell lymphoma.
    Hsi ED; Martin P
    Leuk Lymphoma; 2014 Apr; 55(4):761-7. PubMed ID: 23927395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receiving treatment at a specialist centre confers an overall survival benefit for patients with mantle cell lymphoma.
    McCulloch R; Smith A; Crosbie N; Patmore R; Rule S
    Br J Haematol; 2019 Jun; 185(5):1002-1004. PubMed ID: 30474177
    [No Abstract]   [Full Text] [Related]  

  • 9. Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL Network Phase II Trial.
    Ferrero S; Pastore A; Scholz CW; Forstpointner R; Pezzutto A; Bergmann L; Trümper L; Finke J; Keller U; Ghione P; Passera R; Hiddemann W; Weigert O; Unterhalt M; Dreyling M
    Leukemia; 2016 Apr; 30(4):984-7. PubMed ID: 26242461
    [No Abstract]   [Full Text] [Related]  

  • 10. Disseminated mantle-cell lymphoma presenting as a petechial maculopapular eruption.
    Jawed SI; Hollmann TJ; Moskowitz CH; Desman G; Querfeld C
    JAMA Dermatol; 2014 Jan; 150(1):94-6. PubMed ID: 24258452
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinicopathological Features of Ocular Adnexal Mantle-Cell Lymphoma in an International Multicenter Cohort.
    Knudsen MKH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Khong JJ; McKelvie PA; Mulay K; Ralfkiaer E; Sjö LD; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
    JAMA Ophthalmol; 2017 Dec; 135(12):1367-1374. PubMed ID: 29121219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ten years progression-free survival obtained in a patient with mantle cell lymphoma].
    Wysokińska E; Kolak A; Starosławska E; Kieszko D; Kamińska M; Surdyka D; Mocarska A; Burdan F
    Pol Merkur Lekarski; 2015 May; 38(227):280-2. PubMed ID: 26039024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies.
    Martin P; Chadburn A; Christos P; Furman R; Ruan J; Joyce MA; Fusco E; Glynn P; Elstrom R; Niesvizky R; Feldman EJ; Shore TB; Schuster MW; Ely S; Knowles DM; Chen-Kiang S; Coleman M; Leonard JP
    Ann Oncol; 2008 Jul; 19(7):1327-1330. PubMed ID: 18349031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma.
    Hoster E; Dreyling M; Klapper W; Gisselbrecht C; van Hoof A; Kluin-Nelemans HC; Pfreundschuh M; Reiser M; Metzner B; Einsele H; Peter N; Jung W; Wörmann B; Ludwig WD; Dührsen U; Eimermacher H; Wandt H; Hasford J; Hiddemann W; Unterhalt M; ;
    Blood; 2008 Jan; 111(2):558-65. PubMed ID: 17962512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential prolongation of PFS in mantle cell lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenance.
    Ahmadi T; McQuade J; Porter D; Frey N; Loren AW; Goldstein SC; Svoboda J; Stadtmauer E; Schuster SJ; Nasta SD
    Bone Marrow Transplant; 2012 Aug; 47(8):1082-6. PubMed ID: 22080969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents.
    Inamdar AA; Goy A; Ayoub NM; Attia C; Oton L; Taruvai V; Costales M; Lin YT; Pecora A; Suh KS
    Oncotarget; 2016 Jul; 7(30):48692-48731. PubMed ID: 27119356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of autologous stem cell transplantation on the prognosis of mantle cell lymphoma: a joint analysis of two prospective studies with 46 patients.
    Dreger P; Martin S; Kuse R; Sonnen R; Glass B; Kröger N; Parwaresch R; Kneba M; Schmitz N; Haas R
    Hematol J; 2000; 1(2):87-94. PubMed ID: 11920175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum beta-2 microglobulin as a prognostic biomarker in patients with mantle cell lymphoma.
    Yoo C; Yoon DH; Kim S; Huh J; Park CS; Park CJ; Lee SW; Suh C
    Hematol Oncol; 2016 Mar; 34(1):22-7. PubMed ID: 25689467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns and outcome of relapse after autologous stem cell transplantation for mantle cell lymphoma.
    Dietrich S; Tielesch B; Rieger M; Nickelsen M; Pott C; Witzens-Harig M; Kneba M; Schmitz N; Ho AD; Dreger P
    Cancer; 2011 May; 117(9):1901-10. PubMed ID: 21509767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome for patients with early stage marginal zone lymphoma and mantle cell lymphoma.
    Barzenje DA; Holte H; Fosså A; Ghanima W; Liestøl K; Delabie J; Kolstad A
    Leuk Lymphoma; 2017 Mar; 58(3):623-632. PubMed ID: 27389974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.